Fosun Pharma to pay $240 million for Alma Lasers

Fosun Pharma and Pramerica-Fosun China Opportunity Fund intend to buy a leading Israeli aesthetic medical devices manufacturer.

Fosun Pharma to pay $240 million for Alma Lasers
Alma Lasers is a global developer, manufacturer and provider of lasers for aesthetic and medical applications

Shanghai Fosun Pharma, the subsidiary of Fosun International, and Pramerica-Fosun China Opportunity Fund will pay $240 million for up to 95.6% of Israel-based Alma Lasers.

It is Fosun Pharma’s first international healthcare acquisition since its Hong Kong H-share listing in October last year. According to IMS Health Incorporated, Fosun was one of the top five domestic companies in China by revenue in the pharmaceutical manufacturing segment in 2011.

China is one...

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES